100% procedural success of evaluable patients at 6 months (75/75) 96% procedural success of evaluable patients at one year ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5?8 in Boston, where new clinical data ...
Heart health is often overlooked until warning signs appear. According to the National Institutes of Health, atrial ...
Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field Ablation ...
More than 8 million people in the U.S. take blood thinners, also called anticoagulants. Many are prescribed the drugs after ...
I put Withings’ new BeamO thermometer to the test for several weeks to determine who could benefit from its four-in-one ...
Apple smart watches should be available on the NHS for patients with a common heart rhythm disorder, leading experts have ...
Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field AblationCARDIFF ...
As the ASC industry continues to grow, ASCs have increasingly become sites of innovation and important points of access for surgical care. Here are three notable ‘firsts’ in the ASC industry so far in ...
Drinking coffee can increase lifespan and decrease risk of type 2 diabetes, liver disease, cardiovascular disease, ...
Investor's Business Daily on MSN
Bristol Myers expects sales to decline this year; so why is the stock rising?
Bristol Myers Squibb stock rose moderately Thursday on better-than-expected fourth-quarter metrics and a strong 2026 outlook.
Boston Scientific Corporation (NYSE:BSX) Q4 2025 Earnings Call Transcript February 4, 2026 Boston Scientific Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results